Literature DB >> 6698210

Biological activities of chemically synthesized analogues of the nonreducing sugar moiety of lipid A.

M Matsuura, Y Kojima, J Y Homma, Y Kubota, A Yamamoto, M Kiso, A Hasegawa.   

Abstract

Biological activities of five synthetic lipid A analogues (D-glucosamine derivatives) were examined to elucidate the structure required for expression of the biological activities of endotoxin. Proclotting enzyme of horseshoe crab activation, interferon-inducing and tumor necrosis factor-inducing activities were significantly expressed by an analogue which possesses 4-O-phosphoryl, 3-O-tetradecanoyl and N-tetradecanoyloxytetradecanoyl groups. The results obtained with different analogues show that the 4-O-phosphoryl and N-tetradecanoyloxytetradecanoyl groups are important for expression of the above activities. The effect of 6-O-acylation in preventing the expression of these biological activities is also suggested. Pyrogenic activity was not detected in any of the compounds tested.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6698210     DOI: 10.1016/0014-5793(84)80131-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  Immunopharmacological activities of 2-keto-3-deoxyoctonic acid-(alpha 2----6)-linked 4-O-phosphono-D-glucosamine derivatives carrying N- and 3-O-acyl substituents.

Authors:  Y Kumazawa; M Matsuura; J Y Homma; T Furuya; H Takimoto; K Inagaki; T Nagumo; M Kiso; A Hasegawa
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

2.  Biological activities of chemically synthesized 2-keto-3-deoxyoctonic acid-(alpha 2----6)-D-glucosamine analogs of lipid A.

Authors:  T Shimizu; S Akiyama; T Masuzawa; Y Yanagihara; S Nakamoto; K Achiwa
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

3.  Requirement of a properly acylated beta(1-6)-D-glucosamine disaccharide bisphosphate structure for efficient manifestation of full endotoxic and associated bioactivities of lipid A.

Authors:  I Takahashi; S Kotani; H Takada; M Tsujimoto; T Ogawa; T Shiba; S Kusumoto; M Yamamoto; A Hasegawa; M Kiso
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

4.  Expression of endotoxic activities by synthetic monosaccharide lipid A analogs with alkyl-branched acyl substituents.

Authors:  M Matsuura; S Shimada; M Kiso; A Hasegawa; M Nakano
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

5.  Induction of an endogenous tumor necrosis factor in mice by murine recombinant interferon-gamma combined with a lipid A subunit analog (GLA-60) of low toxicity.

Authors:  I Saiki; H Maeda; T Sakurai; J Murata; J Iida; M Kiso; A Hasegawa; I Azuma
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

6.  Importance of fatty acid substituents of chemically synthesized lipid A-subunit analogs in the expression of immunopharmacological activity.

Authors:  Y Kumazawa; M Nakatsuka; H Takimoto; T Furuya; T Nagumo; A Yamamoto; Y Homma; K Inada; M Yoshida; M Kiso
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

7.  Macrophage activation by monosaccharide precursors of Escherichia coli lipid A.

Authors:  M Nishijima; F Amano; Y Akamatsu; K Akagawa; T Tokunaga; C R Raetz
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

8.  Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy.

Authors:  Erika Vacchelli; Lorenzo Galluzzi; Alexander Eggermont; Wolf Hervé Fridman; Jerome Galon; Catherine Sautès-Fridman; Eric Tartour; Laurence Zitvogel; Guido Kroemer
Journal:  Oncoimmunology       Date:  2012-09-01       Impact factor: 8.110

9.  The use of lipoteichoic acid (LTA) from Streptococcus pyogenes to induce a serum factor causing tumour necrosis.

Authors:  A Yamamoto; H Usami; M Nagamuta; Y Sugawara; S Hamada; T Yamamoto; K Kato; S Kokeguchi; S Kotani
Journal:  Br J Cancer       Date:  1985-05       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.